Share Price:GBX

Day Change:

Intra-Day Volume: 5,000

AIM symbol: REDX
Issued Shares: 126,477,914
Market Cap: £41.74M

Quoted at 12:04:03 BST on 28 April 2017    Data is delayed by 15+ minutes    The London Stock Exchange is currently open

Company Summary

Redx Pharma is an established drug discovery and development company, formed in late 2010. The Group is focused on the development of proprietary, small molecule therapeutics to address areas of high unmet medical need principally in cancer, immunology and infection. Redx Pharma's work has been endorsed by major partnerships with global pharmaceutical companies and the NHS.

Latest Regulatory News

Result of AGM 20 Apr 2017   11:20
Appointment of Chairman 20 Apr 2017   07:00
Notice of Annual General Meeting 07 Apr 2017   15:56
Redx Pharma awarded US$1 million grant by CARB-X 30 Mar 2017   16:03
Final Results Year Ended 30 September 2016 21 Mar 2017   09:05

Share price data and investor tools provided by Brighter IR, subject to their Terms & Conditions

More Regulatory News

Latest Publication

preview image of 2017 AACR: Development of 2nd generation indoleamine 2,3-dioxygenase 1 (IDO-1) selective inhibitors poster

Development of 2nd generation indoleamine 2,3-dioxygenase 1 (IDO-1) selective inhibitors poster,
05 Apr 2017

Latest Video

ProactiveInvestors, 31 Mar 2017

US$1mln grant is ‘testament to the great science’ ongoing at Redx